![]() ![]() Rates of inhaler technique checks and the provision of an asthma action plan were poor, at 4% and 16% respectively. 41% were advised to increase the use of SABA on discharge with no mention of continuing ICS treatment at the same or a higher dose. Although compliance with ICS treatment for most patients was unclear from ED documentation, seven patients were noted to have poor ICS compliance at home. ![]() Only 48% of patients were discharged with an ICS, of whom all but one were already prescribed an ICS prior to presentation. Results: 90 patients met the inclusion criteria, of whom 56% had ≥1 risk factors for exacerbations. Adherence to GINA guidelines was assessed. Methods: We performed a retrospective analysis of the electronic medical records of patients discharged from the Austin Hospital emergency department (ED), between January 2018 and September 2018, following treatment of an asthma exacerbation. Global Initiative for Asthma (GINA) guidelines have recommended ICS treatment in patients with mild asthma, based on clinical studies suggesting that this cohort of patients can have severe or fatal exacerbations 3. Given their absent anti-inflammatory properties, SABA do not treat the underlying airway inflammation and may mask disease progression, hence worsening airway hyper-responsiveness 2. Introduction/Aim: Evidence has shown that asthmatic patients treated with short-acting beta-agonists (SABA) alone are at higher risk of life-threatening exacerbations compared to those on inhaled corticosteroids (ICS) 1. TP 002 Management of acute asthma exacerbations in the emergency department Ang H 1, Wong R 1, Worsnop C 1,2, McDonald C 1,2,3 1Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Australia, 2Institute for Breathing and Sleep, Australia, 3Faculty of Medicine, University of Melbourne, Australia ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |